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trigeminal nerve and subnuclei of limbic
structures in trigeminal neuralgia
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John W. Rutland1, Sheetal Patel3, Joshua Bederson3, Raj K. Shrivastava3, Bradley N. Delman4 and Priti Balchandani1

Abstract
Background: Trigeminal Neuralgia (TN) is a chronic neurological disease that is strongly associated with neurovascular
compression (NVC) of the trigeminal nerve near its root entry zone. The trigeminal nerve at the site of NVC has been
extensively studied but limbic structures that are potentially involved in TN have not been adequately characterized.
Specifically, the hippocampus is a stress-sensitive region which may be structurally impacted by chronic TN pain. As
the center of the emotion-related network, the amygdala is closely related to stress regulation and may be associated
with TN pain as well. The thalamus, which is involved in the trigeminal sensory pathway and nociception, may play a
role in pain processing of TN. The objective of this study was to assess structural alterations in the trigeminal nerve and
subregions of the hippocampus, amygdala, and thalamus in TN patients using ultra-high field MRI and examine
quantitative differences in these structures compared with healthy controls.
Methods: Thirteen TN patients and 13 matched controls were scanned at 7-Tesla MRI with high resolution, T1weighted imaging. Nerve cross sectional area (CSA) was measured and an automated algorithm was used to segment
hippocampal, amygdaloid, and thalamic subregions. Nerve CSA and limbic structure subnuclei volumes were
compared between TN patients and controls.
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Results: CSA of the posterior cisternal nerve on the symptomatic side was smaller in patients (3.75 mm2) compared
with side-matched controls (5.77 mm2, p = 0.006). In TN patients, basal subnucleus amygdala volume (0.347 mm3) was
reduced on the symptomatic side compared with controls (0.401 mm3, p = 0.025) and the paralaminar subnucleus
volume (0.04 mm3) was also reduced on the symptomatic side compared with controls (0.05 mm3, p = 0.009). The
central lateral thalamic subnucleus was larger in TN patients on both the symptomatic side (0.033 mm3) and
asymptomatic side (0.035 mm3), compared with the corresponding sides in controls (0.025 mm3 on both sides, p =
0.048 and p = 0.003 respectively). The inferior and lateral pulvinar thalamic subnuclei were both reduced in TN patients
on the symptomatic side (0.2 mm3 and 0.17 mm3 respectively) compared to controls (0.23 mm3, p = 0.04 and 0.18
mm3, p = 0.04 respectively). No significant findings were found in the hippocampal subfields analyzed.
Conclusions: These findings, generated through a highly sensitive 7 T MRI protocol, provide compelling support for the
theory that TN neurobiology is a complex amalgamation of local structural changes within the trigeminal nerve and
structural alterations in subnuclei of limbic structures directly and indirectly involved in nociception and pain processing.
Keywords: Trigeminal neuralgia, 7-tesla MRI, Thalamic subnuclei, Hippocampal subfields, Amygdala subnuclei, Pain

Introduction
Trigeminal neuralgia (TN) is a chronic and debilitating
disorder, characterized by severe, sudden, and recurrent
facial pain [1]. This condition affects 4.3 per 100,000
people in the United States every year [1] and despite
existing pharmacological and surgical treatment options,
longstanding efficacy remains relatively poor and potential complications and side effects are common [2].
Although TN clearly involves the trigeminal nerve
(Cranial Nerve V, CNV), the precise etiology of TN remains obscure and is an ongoing topic of research [3, 4].
A wide range of etiologies have been described, including neurovascular compression (NVC) [5], multiple
sclerosis [6], tumors [7], arteriovenous malformations
[8], and facial injury [9] among others. NVC [1], as originally described by Janetta [10], is the most commonly
accepted etiology for TN. The nerve is believed to be
most susceptible to pathologic changes from mechanical
compression in the root entry zone (REZ), or transition
zone, just anterior to the nerve’s exit from the pons [9].
This region is thought to be most susceptible to vascular
compression due to its proximity to normal blood vessels as well as fragility in the myelin associated with
transition from oligodendrocyte to Schwann cell myelin.
Vascular contact in the REZ can lead to demyelination
and abnormal nerve conduction causing electrical instability, structural disarray, and atrophy [7].
While NVC is the most common observation in patients with TN, imaging studies suggest that TN can be
present and recur in the absence of demonstrable NVC
on MRI scans [11, 12]. In most cases, proof of compression is not required for treatment. Of those patients with
confirmed NVC who are treated surgically, approximately 30% will experience recurrent pain within 10
years [13, 14]. Moreover, the appearance of NVC is often
observed incidentally on MRI scans of individuals who
do not suffer from TN [15]. The disparities between TN

symptoms and NVC based on imaging, as well as the
poor long-term efficacy of surgical treatment, suggest
that NVC may not be the only cause of TN pain, or may
cause changes in other parts of the nociceptive pathways
that in turn cause TN symptomology in a large percentage of patients. Limited understanding of TN etiology is
a significant impediment to developing effective treatments [1, 2, 16].
Multiple magnetic resonance imaging (MRI) studies
have been performed to identify and characterize
possible disease mechanisms of TN. It is becoming
increasingly clear that while chronic pain in TN
directly involves structural abnormalities at the level
of compression at the trigeminal nerve REZ, with reduced cross-sectional area (CSA) and volume of the
trigeminal nerve on the symptomatic side [17–20],
broader structural disorder in pain-related limbic
regions may be a critical component of TN
pathophysiology as well [21, 22]. Tian et al. found
differences in local functional connectivity density of
the thalamus, hippocampus, and other regions
outside the trigeminal nerve in TN [23]. Danyluk
et al. showed that greater preoperative trigeminal
nerve and hippocampal volumes may predict early
non-response to surgical treatment for TN [24].
Zhang et al. demonstrated decreased grey matter
volumes in the bilateral amygdala [22]. Vaculik et al.
found volumetric reductions in ipsilateral hippocampal subfields in two cornu ammonis (CA) regions,
CA1 and CA4, as well as in the dentate gyrus (DG)
in TN patients [25]. Noorani et al. found that pain
relief can reverse hippocampal abnormalities in
trigeminal neuralgia and suggests that hippocampal
volume reduction in TN is pain-driven [26]. These
findings provide strong premise and motivation for
further investigation of trigeminal nerve anatomy and
subregions of limbic structures with hypothesized
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involvement in TN pain. The hippocampus, amygdala,
and thalamus are of particular interest when it comes to
exploring TN pathophysiology. The hippocampus is a
stress-sensitive structure which can undergo changes in
the presence of chronic pain [21, 25, 26]. The amygdala,
which is the hub of the emotion-related network and
involved in stress regulation, may be associated with pain
in TN as well [21, 27]. Finally, the thalamus, which is involved in nociception and the trigeminal sensory pathway,
is also implicated in TN [23, 28]. Further evaluation of
these findings can promote a more comprehensive understanding of TN etiology and pain from localized nerve
effects due to compression as well as more global, circuitlevel effects.
Many of the MRI studies on TN have been performed
at conventional clinical field strengths, including 1.5and 3-Tesla, whose architecture and physics limit
resolution and quantitative rigor especially for small
structures. Clinical MRI protocols at conventional field
strengths currently lack the sensitivity, specificity, and
scope required to fully characterize elements of the TN
pathway, such as trigeminal nerves themselves as well as
subnuclei of limbic structures. Investigation of these
subregions with increased anatomical detail can facilitate
characterization of TN pathophysiology in these regions
and may potentially identify novel targets for treatment
and pain management.
Ultra-high field strength MRI scanners, including
those operating at 7-Tesla (7 T), offer increased
signal-to-noise ratio (SNR) [29] and enhanced
contrast and resolution compared to conventional
clinical scanners. 7 T imaging can reveal subtle
anatomical alterations which are below the threshold
of detectability at lower field strengths and enhance
depiction of smaller structures including trigeminal
nerves, hippocampal subfields, and subnuclei of the
amygdala and thalamus. The purpose of this study is
to leverage the enhanced SNR and resolution offered
by ultra-high field MRI to quantify structural properties of
the trigeminal nerve and calculate the volumes of
subregions of the thalamus, hippocampus, and amygdala
in patients with TN and matched healthy controls. This
analysis, therefore, characterizes the primary and
secondary brain regions that may be implicated in TN
pathophysiology. We anticipate that the findings yielded
through the highly sensitive imaging protocol in this study
will aid in treatment options for TN as well as improve
understanding of disease pathophysiology. Using structural neuroimaging to investigate changes in the nerve
and limbic structure subnuclei in TN could provide a
noninvasive method to monitor treatment progression,
evaluate drug treatments in clinical trials, and potentially
differentiate the different causes of TN based on
underlying mechanisms.
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Methods
Subjects

Patients with TN between the ages of 18 and 75 years
old were recruited through our clinical collaborators (RS
and JB) from the Department of Neurosurgery at Mount
Sinai Hospital. All patients were diagnosed by a neurologist based on medical history and a physical examination. Subjects with a contraindication to MRI were
excluded from the study. Written informed consent was
provided by all subjects prior to the study, which was
approved by the local Institutional Review Board. Clinical
information, including disease duration, was obtained for
all TN patients.
Imaging protocol

Subjects underwent scanning with a Magnetom 7 T
whole body MRI scanner (Siemens, Erlangen, Germany)
equipped with 70 mT/m gradients (SC72CD, Siemens)
and single-channel transmit, 32-channel receive head
radiofrequency coil (Nova Medical, Wilmington, MA).
The protocol included a 2D oblique-coronal T1weighted MP2RAGE sequence for volumetric analysis,
with the following parameters: TE 3.62 ms, TR 3000 ms,
flip angle 7 degrees, matrix size 320 × 240, 224 slices, acceleration factor of 2, and 0.7 mm3 isotropic resolution.
Nerve cross-sectional area

The cross-sectional area (CSA) of the nerve was measured by manually tracing regions of interest (ROIs) on
high-resolution, oblique-coronal T1-weighted MP2RAGE
images using Horos, an open source DICOM viewing
software. Nerve ROIs were drawn by a trained image
analyst (JA) and guided by a neuroradiologist (BD) with
Certificate of Added Qualification (CAQ) in neuroradiology. A total of four ROIs were traced for each subject,
with two ROIs traced on the left trigeminal nerve and
two on the right trigeminal nerve. For each nerve, the
first ROI was traced at the most posterior point where
the nerve emerges from the pons and the second ROI at
the most anterior point just before the nerve enters
Meckel’s cave. The CSA was quantified for each nerve
ROI and group comparisons of CSA values on the symptomatic and asymptomatic sides were performed.
Segmentation of subnuclei of limbic structures

Segmentation of the hippocampus, amygdala, and their
subfields were performed using an automated segmentation software, Freesurfer image analysis suite version 6.0
(http://surfer.nmr.mgh.harvard.edu). Segmentation of
the thalamus and its subnuclei was performed using
Freesurfer version 7.0 [ 30]. A summary of the regions
analyzed is shown in Fig. 1 (see Additional file 2).
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Statistical analysis

All limbic structure subnuclei volumes were normalized
to total brain volume, which was also provided by
Freesurfer 6.0. We performed two-tailed, independent
Student’s t-tests to compare structural data between TN
patients and controls, with the symptomatic side in patients compared to the same side in matched healthy
controls (side-matched). P < 0.05 was considered significant. Effect sizes (Cohen’s d) were also calculated for
each comparison.
Due to the heterogeneity in the trigeminal neuralgia
patients, analyses were also performed on the subset of
nine classical, purely paroxysmal trigeminal neuralgia
patients for all significant findings in the larger group.
A total of two nerve ROIs, six hippocampal regions,
ten amygdala regions, and twenty-six thalamic regions
were quantified for each nerve and compared between
patients and controls. Correction for multiple comparisons was performed with false discovery rate (FDR)
correction.
Since our t-tests assume a standard distribution, we
performed permutation testing, a type of statistical significance test, to check the significant values for false
positives and verify the statistical significance of our
model. The method of permutation testing is similar to
that performed in a study by Jacob et al. [31] With permutation testing, we obtained the distribution of the test
statistic under the null hypothesis, which would be no
significant differences between the patient and healthy
control groups. This involved combining and then shuffling the sample patient and control values randomly
one thousand times (k = 1000) to create a simulated
population distribution of the test statistic for each random rearrangement of our data points. We then compared it to our data’s t-statistic to obtain a permutationderived p value. This is especially beneficial for our study
containing multiple statistical tests, since the assumptions and/or approximations required for parametric
tests may not be satisfied for each and every test and
correlation across tests can be difficult to account for.
While it is not a correction for multiple comparisons,
permutation testing is beneficial as a method to determine whether the significant findings are due to random
chance or driven by real effects.
We also investigated the correlation of structural
changes in TN with disease duration for each significant
subnucleus finding. The correlations were performed
using linear regression.

Results
Thirteen TN patients (mean age 42.9 years, standard deviation 12.2 years, 5 males and 8 females) and thirteen
healthy controls matched for age and gender (mean age
42.5 years, standard deviation 10.2 years) were included
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in this study. Age was not significantly different between
groups (p = 0.9). There were 23% more females than
males in the cohort, which reflects the greater female
prevalence of the disease in the general population [1].
Nine patients had classical, purely paroxysmal trigeminal
neuralgia and the remaining four patients had secondary
trigeminal neuralgia, as determined by ICHD-3 criteria.
Clinical information for all TN patients are provided in
Table 1 (see Additional file 1).
Structural changes in TN patients

Table 2 (see Additional file 1) includes a summary of
significant findings (defined as p < 0.05) and their effect
sizes in the full sample of TN patients compared to
controls. The significant findings did not survive FDR
correction for multiple comparisons. However, permutation testing performed on each of these findings resulted
in significant permutation-derived p values (defined as
p < 0.05) and are included in the table as well.
Nerve cross sectional area

The CSA of the trigeminal nerve at exit from the pons
was found to be significantly lower in TN patients on
the symptomatic side (3.75 mm2, p = 0.0057, d = − 1.19)
compared to the same side in healthy controls (5.77
mm2). No significant difference in CSA was found on
the asymptomatic side.
Differences in CSA of the anterior point along the
nerve where it enters Meckel’s cave did not reach significance on either the symptomatic or asymptomatic side.
Hippocampal subfield volumes

Volumetric differences were evaluated in segmented hippocampal subfields of interest, including CA1, CA3,
CA4, DG, subiculum, and the whole hippocampus on
each side. When comparing patients to controls, the
volumetric differences in these regions did not reach significance on either the symptomatic or asymptomatic
side.
Amygdala subnuclei volumes

The basal nucleus of the amygdala was found to be significantly smaller on the symptomatic side in patients (0.35
mm3, p = 0.025, d = − 0.94) compared to the corresponding
side in controls (0.40 mm3). No significant difference in
basal nucleus volume was found on the asymptomatic side.
The paralaminar nucleus was also found to be significantly
smaller in patients (0.039 mm3, p = 0.009, d = − 1.12) compared to controls (0.047 mm3) on the symptomatic side.
The other amygdala subnuclei segmented, including lateral,
accessory-basal, anterior-amygdaloid, central, medial,
cortical, and cortico-amygdaloid, as well as total amygdala
volume, were not significantly different between patients
and controls on the symptomatic or asymptomatic side.
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Thalamic subnuclei volumes

The central lateral (CL) subnucleus ipsilateral to TN was
significantly larger in patients (0.033 mm3, p = 0.048,
d = 0.819) compared to controls (0.025 mm3). The CL
subnucleus on the side contralateral to pain was also
found to be larger in patients (0.035 mm3, p = 0.003, d =
1.32) compared to controls (0.025 mm3). The lateral
pulvinar (PuL) subnucleus on the symptomatic side was
found to be significantly smaller in patients (0.17 mm3,
p = 0.042, d = − 0.84) compared to controls (0.18 mm3).
The inferior pulvinar (PuI) subnucleus on the symptomatic side was also found to be significantly smaller in
patients (0.1998 mm3, p = 0.044, d = − 0.83) compared to
controls (0.226 mm3). Other thalamic subnuclei in the
anterior, lateral, ventral, intralaminar, medial, and posterior, as well as total thalamic volume, were not significantly different between patients and controls on either
the symptomatic or asymptomatic side.
Illustrative ROIs and segmentation results in a single
TN subject, which provide the basis of the CSA and volumetric analyses, are shown in Fig. 2 (see Additional file 3).
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0.0074, d = 1.45) compared to controls (0.030 mm3). The
inferior pulvinar (PuI) subnucleus on the symptomatic
side was found to be significantly smaller in these patients (0.20 mm3, p = 0.0052, d = − 1.52) compared to
controls (0.23 mm3). However, the finding in the lateral
pulvinar (PuL) on the symptomatic side did not persist
in this TN subset. The finding in the CL subnucleus ipsilateral to TN also did not persist in this TN subset and
had only borderline significance with a large effect size
(p = 0.051, d = 0.99).
Relationship between structural changes and disease
duration

Linear regressions were performed for each significant
subnucleus volume difference versus disease duration.
No statistically significant correlations were found in the
full TN cohort, nor in the subset of classical, purely paroxysmal patients.

Due to the heterogeneity in the trigeminal neuralgia patients, analyses were performed on the subset of nine classical, purely paroxysmal TN patients for all significant
findings in the larger group. Table 3 (see Additional file 1)
includes a summary of significant findings in the subset of
nine classical, purely paroxysmal TN patients, and their effect sizes. Permutation testing performed on each of these
findings resulted in significant permutation-derived p
values (defined as p < 0.05) and are included in the table.

Discussion
Advanced imaging studies are increasingly being applied
to study TN. Studies have shown structural changes in trigeminal nerves [17–20] and limbic structures [21, 23–26]
in the presence of TN pathology. In this study, ultra-high
field MRI provided excellent resolution of the trigeminal
nerves as well as granular subregions of the hippocampus,
amygdala, and thalamus. The purpose of this exploratory
study was to identify potential structural changes which
may be associated with TN pathophysiology and that can
be further explored in future studies. Analyses including
comparison of CSA of the nerves and volumes of limbic
structure subregions between patients and controls were
performed.

Nerve cross sectional area in classical subset

Structural changes in TN patients

The CSA of the trigeminal nerve at the point of exit
from the pons was found to be significantly lower in
classical, purely paroxysmal TN patients on the symptomatic side (3.12 mm2, p = 0.0075, d = − 1.44) compared to the same side in healthy controls (5.67 mm2).

The data in this pilot study revealed that the CSA of the
trigeminal nerve was reduced on the symptomatic side,
specifically in the region where the nerve exits the pons,
in patients compared to controls. The symptomatic side
corresponded to the compressed side for patients with
NVC. Although the exact cause of reduced CSA, such as
compression or pathologic volume loss, is not identifiable
given our data, reduced CSA of the nerve on the symptomatic side in patients compared to controls is consistent
with the hypothesis that NVC plays a role in TN. Reduced
CSA was shown at the posterior point along the nerve’s
trajectory where it exits the brainstem, and not where the
nerve enters Meckel’s cave. This is consistent with the
theory that the compression of posterior portion of the
nerve is more likely to be associated with symptomatic
TN than compression of the anterior portion.
The data also showed differences between patients and
controls in subnuclei of limbic structures with hypothesized
involvement in TN, including the basal and paralaminar

Structural changes in classical, purely paroxysmal TN
patients

Amygdala subnuclei volumes in classical subset

The basal nucleus of the amygdala was found to be significantly smaller on the symptomatic side in classical,
purely paroxysmal patients (0.33 mm3, p = 0.017, d = −
1.26) compared to the corresponding side in controls
(0.41 mm3). However, the paralaminar nucleus on the
symptomatic side, was not found to be significantly
smaller in this subset of patients compared to controls.
Thalamic subnuclei volumes in classical subset

The central lateral (CL) subnucleus on the side contralateral to pain was found to be larger in this subset of
classical, purely paroxysmal patients (0.037 mm3, p =
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subnuclei in the amygdala on the symptomatic side, the inferior and lateral pulvinar thalamic subnuclei on the symptomatic side, and the central lateral nucleus of the thalamus
on the symptomatic and asymptomatic sides.
The basal nucleus is one of the main sources of amygdala output to the ventral striatum which is involved in
modulating pain [32]. We observed reduced basal
nucleus volume in TN patients, potentially indicating
inadequate pain modulation and processing in TN. The
function of the paralaminar subnucleus of the amygdala
is poorly understood at this time [33]. We observed reduced paralaminar nucleus volume in TN suggesting
that this region may play a role in pain.
The thalamic subnuclei volumes which appear significantly different between patients and controls in our
analysis do not necessarily represent the areas expected
to be involved in TN neurobiology. While the thalamic
subnucleus most directly involved in nociception in the
trigeminal sensory pathway is the contralateral ventral
posteromedial nucleus (VPM), no significant volume loss
was noted in our analysis. Instead, we observed increased volume in the central lateral nucleus of the thalamus in TN patients on the symptomatic side in the full
TN patient cohort and the asymptomatic side in both
the full cohort and the subset of classical, purely paroxysmal TN patients. Multiple studies have established the
posterior part of the CL (CLp) nucleus as a target in
chronic therapy-resistant neurogenic pain, including trigeminal pain. The CLp transfers nociceptive information
through the spinothalamic and spinoreticulothalamic
pathways to large areas of cortex, including the insula
and anterior cingulate cortex which are involved in nociception [34]. Although trigeminal sensation is carried in
the trigeminothalamic tract which is distinct from the
spinothalamic tract, they are analogous in that they are
both involved in nociception. The increased volume of
the CL subnucleus observed on both the symptomatic and
asymptomatic sides in TN patients may indicate a systemic,
compensatory effect in response to neurogenic pain.
While the pulvinar subnucleus of the thalamus is
thought to be mainly involved in processing visual
stimuli, this region is proposed to also be involved in
proprioception and multisensory processing, including
pain [35]. This supports the notion that the reduced
inferior and lateral pulvinar volumes we observed on the
symptomatic side in TN patients may reflect the role of
the pulvinar in pain processing.
Additional analyses, including t-tests and permutation
tests, were performed on the homogenous subgroup for
all significant findings in the full patient cohort.
Although the sample size of this subset is < 10, it was
important to perform further analysis to avoid mixing
TN diseases with diverse clinical manifestation and
pathophysiology. Since there were significant findings
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which persisted in this homogenous subset, especially in
the nerve CSA, we were able to determine that these
findings were not due to tumor-related compressive
effects.
Limitations and future directions

One limitation of this study is the small sample size.
This was an exploratory study in a rare disease, limiting
the rate of recruitment. Despite this, potentially significant differences were found between TN patients and
healthy controls in this dataset, providing targeted nerve
and limbic subnuclei regions for future high resolution
7 T studies. Analysis with a larger sample size is needed
to validate these findings with sufficient power.
The source of CSA reduction is unknown; potential
causes could be compression or atrophy. Ascertaining
the mechanism of CSA reduction is beyond the scope of
this study and may be investigated using a study with a
larger sample size containing patients with several TN
etiologies. It is possible that compression leads to nerve
atrophy over time, but since the patients in this study
were imaged prior to intervention it is also possible that
the finding of reduced CSA represents the compression
itself rather than atrophy.
The findings reported in this study in areas beyond
the confines of the trigeminal nerves (i.e., the amygdala
and thalamus) may constitute downstream effects and
abnormalities that might potentiate, contribute or
enhance TN. Effects in brain regions related to chronic
pain, specifically in granular limbic structure regions
with potential involvement in pain modulation and processing, require further study with a larger dataset to be
fully characterized.
While the subjects in this study reflected the greater
prevalence of TN in females compared to males, a comparison of structural findings in the two sexes was not
feasible in our cohort, because of the small sample size
of the male and female subsets. This analysis would be
warranted in a future study with a larger cohort.
Prior literature suggests that hippocampal changes
may differ in males versus females as hormones have
been shown to play a role in hippocampal abnormalities
in animal [36–38] and human studies [39–41]. A larger
study is warranted to evaluate correlations between
changes in hippocampal subfield volumes and sex in a TN
cohort as future work. Since hippocampal volume is also
sensitive to baseline cortisol levels [42], this study would
need to control for individual cortisol levels in the cohort.
It has also been demonstrated that some drugs used
for TN, such as antiepileptic drugs, can result in
morphological neurodegenerative changes in animal
models [43] as well as reduced hippocampal betweenness centrality (which is a measure of functional connectivity) in humans [44]. Evaluation of drug effects on
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neurodegenerative imaging biomarkers is warranted in
future studies with a larger sample size.
Although no effects were shown in subnucleus volumes versus disease duration, this correlation should be
explored further in future work with a larger cohort to
validate previous findings which suggest that duration of
symptoms may be linked to structural alterations in
TN26. Future work evaluating the intensity of TN
attacks, presence of sensory deficit, and allodynia can
further elucidate the relationship between pain and
structural changes in TN.

Conclusions
This study is a preliminary investigation of structural alterations in the trigeminal nerve and subnuclei of limbic
structures in TN patients using ultra-high field MRI and
examines quantitative differences in these structures versus healthy controls. These results provide compelling
support for the theory that TN pathophysiology is a
complex mixture of local structural alterations in the trigeminal nerve as well as alterations in the structure and,
potentially, function of various brain regions directly and
indirectly involved in nociception and pain processing.
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